Column Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $28.8M | Hold |
|
|||||
|
2023
Q4 | $15.6M | Hold |
|
|||||
|
2023
Q3 | $19.4M | Hold |
|
|||||
|
2023
Q2 | $47M | Hold |
|
|||||
|
2023
Q1 | $74M | Hold |
|
|||||
|
2022
Q4 | $91M | Hold |
|
|||||
|
2022
Q3 | $237M | Hold |
|
|||||
|
2022
Q2 | $233M | Buy |
|
|||||
|
2022
Q1 | $248M | Buy |
|
|||||
|
2021
Q4 | $273M | Hold |
|
|||||
|
2021
Q3 | $324M | Hold |
|
|||||
|
2021
Q2 | $304M | Hold |
|
|||||
|
2021
Q1 | $448M | Hold |
|
|||||
|
2020
Q4 | $467M | Buy |
|